Induction of immune tolerance to caseins and whey proteins by oral intubation in mouse allergy model

This study was designed to evaluate the effect of oral tolerance of caseins (CSN) and whey proteins (WP) in alleviating the allergic response to cow's milk proteins in Swiss albino mice raised on a milk protein–free diet. Oral tolerance was induced by feeding mice with 20 mg of CSN or WP once in a day for 4 days consecutively before immunization with respective protein by intraperitoneal (i.p.) injections (20 μg 200 per μl of PBS) using 2% of alum Al(OH)₃ as adjuvant. Three weeks later, oral tolerance induction was analysed in humoral and cellular compartments of CSN‐ and WP‐fed versus saline‐fed control mice groups by measuring seric and intestinal antibody responses, mRNA abundance in splenic tissue and cytokine secretion patterns. The specific serum immunoglobulin‐E (IgE) levels were significantly suppressed (p < 0.05), while sIgA was enhanced in these groups when compared with their respective saline‐fed mice. Moreover, the mRNA levels of interferon‐γ (IFN‐γ) and interleukin‐4 (IL‐4) in both CSN‐ and WP‐tolerized mice were found to be significantly decreased, while the abundance of interleukin‐10 (IL‐10) and transforming growth factor‐β (TGF‐β) was increased significantly, as compared to respective control groups. Finally, cytokine profiles indicated a reciprocal decrease in IL‐4 and IFN‐γ versus an increase in IL‐10 secretions in supernatants of cultured splenocytes of tolerized mice. Taken together, these results clearly showed that oral administration of cows' milk caseins and whey proteins can induce significant hyposensitization in mice, with the participation of suppressor cytokines.     

气相色谱法测定苦参苍术口服液中三氯甲烷残留量

建立了苦参苍术口服液中三氯甲烷残留量的气相色谱检测方法,采用DB—FFAP毛细管柱,柱温为程序升温,氢火焰离子化检测器（FID）,检测器温度为250℃,进样口温度为220oC,载气为氮气。试验结果三氯甲烷在6．0464～120．928μg／mL浓度范围内呈良好的线性关系（r=0．99995）,加样回收实验平均回收率为98．01％（RSD=1．6％）。本方法简便、快速、准确、重现性好,可作为苦参苍术口服液中三氯甲烷残留量的检测方法。     

口服嗜水气单胞菌生物被膜疫苗的动物免疫试验

将热灭活的嗜水气单胞菌(Aeromonashydrophila)生物被膜(biofilm,BF)菌苗和浮游(freecell,FC)菌苗口服免疫小鼠和剑尾鱼,通过测定抗体效价、相对保护率、小鼠的淋巴细胞转化和肠道sIgA浓度,评价免疫效果。免疫20d后,BF菌苗组50尾剑尾鱼的相对保护率为68%;FC菌苗组为42%。BF菌苗组12只小鼠的相对保护率为70%;FC菌苗组为50%;对照组为17%。BF菌苗组小鼠外周血淋巴细胞转化率是7.28、FC菌苗组为3.87、对照组为2.36。BF菌苗组小鼠肠道sIgA浓度是1.22μg/mL;FC菌苗组为0.73μg/mL;对照组为0.465μg/mL。免疫30d后,小鼠的血清凝集抗体达到最高,BF组抗体达128:1,FC组为32:1,对照组为2:1。各组间差异显著(P<0.01)。结果表明,BF菌苗较FC菌苗能更有效地刺激机体的免疫系统,尤其是肠道淋巴组织的免疫应答,对剑尾鱼和小鼠具有较好的保护力。     

平鲉微杯虫的扫描电镜观察

扫描电镜观察平鲉微杯虫（Microcotyle sebastisci Yamaguti，1958）显示：该虫中型个体，具口吸盘1对，口吸盘之间可见口孔，具横隔。口孔正下方为一圆形生殖孔，卵纺锤形具双极丝。后吸器鸡冠状，上面对称排列着两行无柄微杯型吸铗，吸铗形状、大小相近。体表具横向皱褶，背面体表具乳头状乳突，腹面体表密披杆状纤毛。[中国水产科学，2006，13（4）：511—516]     

奶山羊乳房炎灭活疫苗的制备及免疫效果检测

为评估奶山羊乳房炎灭活疫苗的免疫效果,以大肠埃希菌、金黄色葡萄球菌、凝固酶阴性表皮葡萄球菌及产色葡萄球菌为材料,经甲醛37℃灭活,按照6∶1（V／V）与铝胶盐充分混匀,分别经腹股沟皮下、颈部皮下注射途径,免疫泌乳期奶山羊,免疫剂量均为2 mL,共免疫2次,每次间隔14 d。分别在免疫前及第1次免疫后10、24、60、180 d 采集血样和乳样,ELISA 测定抗体效价,用快速诊断液检测隐性乳房炎,统计患病奶山羊的数量。结果显示,与对照组相比,两次免疫后血液及乳汁中针对大肠埃希菌、金黄色葡萄球菌、凝固酶阴性表皮葡萄球菌及产色葡萄球菌的抗体效价含量均显著增加（P ＜0．05）,抗体维持时间长;颈部皮下免疫组免疫后180 d,腹股沟皮下免疫组免疫后的60 d,隐性乳房炎奶山羊数量均明显下降。结果表明,本研究制备的奶山羊乳房炎疫苗不仅能够刺激机体产生较好的体液免疫应答,而且还对隐性乳房炎有显著的治疗效果。     

Sedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular administration in cats

ObjectiveTo compare sedation and antinociception after oral transmucosal (OTM) and intramuscular (IM) administration of a dexmedetomidine-buprenorphine combination in healthy adult cats.Study designRandomized, ‘blinded’ crossover study, with 1 month washout between treatments.AnimalsSix healthy neutered female cats, weighing 5.3–7.5 kg.MethodsA combination of dexmedetomidine (40 μg kg^?1) and buprenorphine (20 μg kg^?1) was administered by either the OTM (buccal cavity) or IM (quadriceps muscle) route. Sedation was measured using a numerical rating scale, at baseline and at various time points until 6 hours after treatment. At the same time points, analgesia was scored using a dynamic and interactive visual analogue scale, based on the response to an ear pinch, and by the cat’s response to a mechanical stimulus exerted by a pressure rate onset device. Physiological and adverse effects were recorded, and oral pH measured. Signed rank tests were performed, with significance set at p < 0.05. Data are presented as median and range.ResultsThere were no differences in sedation or antinociception scores between OTM and IM dosing at any of the time points. Nociceptive thresholds increased after both treatments but without significant difference between groups. Buccal pH remained between 8 and 8.5. Salivation was noted after OTM administration (n = 2) and vomiting after both OTM (n = 4), and IM (n = 3) dosing.Conclusions and clinical relevanceIn healthy adult cats, OTM administration of dexmedetomidine and buprenorphine resulted in comparable levels of sedation and antinociception to IM dosing. The OTM administration may offer an alternative route to administer this sedative-analgesic combination in cats.     

Oral and maxillofacial osteosarcoma in dogs: a review

Osteosarcoma in dogs is a heterogeneous disease entity with regard to its histologic, clinical and biologic behaviour. Differences in behaviour are associated with tumour location. Oral and maxillofacial osteosarcomas are typically reported as a component of the broader classifications of axial osteosarcoma or osteosarcoma of flat bones to differentiate them from appendicular osteosarcoma. Similar to human oral and maxillofacial osteosarcoma, in dogs, these also appear to have less aggressive behaviour than appendicular osteosarcoma. Ideally, local control is achieved with wide surgical resection that results in tumour‐free margins. Failure of local control is the most common contributor to poor prognosis. Chemotherapy and radiation treatment are reported to have variable outcomes. The aim of this article is to review the literature on oral and maxillofacial osteosarcoma in dogs in comparison to appendicular and axial osteosarcoma. Similarities and differences between oral and maxillofacial osteosarcoma in humans are addressed.     

The expression of calretinin and cytokeratins in canine acanthomatous ameloblastoma and oral squamous cell carcinoma

Oral squamous cell carcinoma (OSCC) and canine acanthomatous ameloblastoma (CAA) represent two epithelium‐derived neoplasms that affect the oral cavity of dogs. The expression of cytokeratins (CKs) and calretinin has been previously established in the canine tooth bud and odontogenic tumours. The aim of this study was to characterize the CK and calretinin expression profile of OSCC in comparison to CAA and canine tooth bud tissues. Samples from 15 OSCC and 15 CAA cases, as well as 6 tooth buds and 2 normal gingival tissues were examined. OSCC CK expression was consistent with the CK expression profile of CAA and canine tooth bud tissue. Calretinin was positively expressed in 10 of 15 OSCC cases, with 5 cases demonstrating high staining intensity. Only 2 of 15 CAA cases demonstrated mild‐moderate staining intensity. The statistically significant difference in staining pattern and intensity of calretinin in OSCC and CAA can help distinguish between these two tumour types.     

Evaluation of 6 ONRAB Ultralite bait flavor matrices delivered to coyotes (Canis latrans): Implications for oral rabies vaccination

The spread of rabies in terrestrial wildlife throughout the United States is primarily controlled through oral rabies vaccination. Relatively low bait acceptance and seroconversion rates by some target species have prompted investigation into an alternative to the RABORAL V-RG bait currently used. In Canada, ONRAB Ultralite baits are used to vaccinate raccoons (Procyon lotor) and striped skunks (Mephitis mephitis). Comparative studies between RABORAL V-RG and ONRAB found higher seroconversion rates among raccoons that ingested ONRAB, suggesting that it may be a suitable alternative. However, ONRAB has not been evaluated in many rabies reservoir species, including coyotes (Canis latrans). Vaccination of coyotes is a critical element in preventing reemergence of canine strain of rabies in the United States. We evaluated flavor preference of ONRAB Ultralite oral rabies vaccine baits by coyotes. Preferences among bait types differed (Friedman χ² = 13.28; df = 5; P = 0.02). Of the 6 bait flavors evaluated, cheese ranked the highest, followed by fish, chicken, sugar-vanilla, egg, and bacon flavors. Pairwise trials among the top 3 flavors (cheese, fish, and chicken) showed no difference (Friedman χ² = 3.00; df = 2; P = 0.22). Our research suggests that among the bait flavors we evaluated, cheese, fish, or chicken-flavored baits may be an appropriate flavor for delivery of ONRAB Ultralite baits to coyotes.